Comparison of two fixed beta-blocker-pilocarpine combinations. The Carteolol-Pilocarpine Study Group

Autor: Bron, Alain M., Garcher, Catherine P., Sirbat, D., Allaire, C. M., Lablache-Combier, M. J., Trinquand, C. J.

Publikováno v: European Journal of Ophthalmology
European Journal of Ophthalmology, Wichtig Editore, 1997, 7 (4), pp.351-356. ⟨10.1177/112067219700700408⟩

To compare the efficacy and safety of a newly developed ophthalmic solution containing carteolol 2% and pilocarpine (2% (CBS341A) with a timolol 0.5% and pilocarpine 2% fixed combination. A randomized, double-masked, multicenter study was conducted i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4155556daec8406752b15558eba83b2c
https://pubmed.ncbi.nlm.nih.gov/9457458

Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients

Autor: Renard, P., Kovalski, J., Cochereau, I., Jaulerry, S., Williamson, W., Elena, P., Lablache Combier, M., Allaire, C., Siou-Mermet, R.

Publikováno v: Graefe's Archive for Clinical and Experimental Ophthalmology; December 2005, Vol. 243 Issue: 12 p1221-1227, 7p

[Comparative prospective study of effects of Biovisc and Healonid on endothelial cell loss and intraocular pressure in cataract surgery].

Autor: Colin J; Hôpital Morvan, Brest., Renard G, Ullern M, Lablache Combier M, Richard C, Trinquand C

Publikováno v: Journal francais d'ophtalmologie [J Fr Ophtalmol] 1995; Vol. 18 (5), pp. 356-63.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.